Abstract
Objective Circulating miRNAs are found in bodily fluids including plasma and can serve as biomarkers for diseases. The aim of this study was to provide the first insight into the landscape of circulating miRNAs in close proximity to the adrenocorticotropic hormone (ACTH) secreting PitNET. To achieve this objective next-generation sequencing of miRNAs in plasma from bilateral inferior petrosal sinus sampling (BIPSS) - a gold standard in diagnosing ACTH-secreting PitNETs, was carried out.
Methods Sinistral (left) and dextral (right) BIPSS blood samples of the patient were collected in three time points: before the administration of corticotropin-releasing hormone, 5 and 15 minutes after stimulation. Peripheral venous blood samples were also collected 24 hours before and after BIPSS and before the resection of PitNET and 24 hours after. In differential expression analysis sinistral plasma was compared with dextral.
Results BIPSS concluded that the highest amount of ACTH was released in the sinistral side at the 5th minute mark indicating a presence of tumor. The highest amount of differentially expressed miRNAs was observed 5 minutes after stimulation (20 upregulated, 14 downregulated). At the 5th minute mark in sinistral plasma, two miRNAs were identified: hsa-miR-7-5p and hsa-miR-375-3p that were highly upregulated compared to other BIPSS samples and peripheral plasma samples. Clustering analysis showed that BIPSS plasma differs from peripheral plasma in miRNA expression patterns.
Conclusions data indicates that ACTH-secreting PitNET actively releases two circulating miRNAs upon stimulation with CRH (hsa-mir-7-5p, hsa-mir-375-3p) alongside with ACTH implying further studies of these miRNA as diagnostic markers are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the European Regional Development Fund within the project "RNA molecular determinants in development of pituitary adenoma" (1.1.1.1/18/A/089).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of patient's samples and data in this study was approved by the Central Medical Ethics Committee of Latvia (protocol: 22.03.07/A7 and 2/18-02-21). The patients/participants provided their written informed consent to participate in this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(helvijs.niedra{at}biomed.lu.lv)
(raitis{at}biomed.lu.lv)
(drkonrade{at}inbox.lv)
(inga.balcere{at}rsu.lv)
(mihailsromanovs{at}gmail.com)
(liva.steina{at}biomed.lu.lv)
(janis.stukens{at}stradini.lv)
(sokolovska.jelizaveta{at}lu.lv)
(klovins{at}biomed.lu.lv)
(vita.rovite{at}biomed.lu.lv)
Data Availability
Data supporting the findings that are reported within the manuscript are available in supplementary files. Sequencing data are available in FASTQ file format at Gene Expression Omnibus public repository with accession number: GSE163957. Any additional data is available from corresponding authors upon request.
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163957
Abbreviations
- miRNA
- micro RNA
- PitNET
- pituitary neuroendocrine tumor
- BIPSS
- bilateral inferior petrosal sinus sampling
- IPS
- inferior petrosal sinus
- PVB
- peripheral venous blood
- CRH
- corticotropin-releasing hormone
- hCRH
- human corticotropin-releasing hormone
- ACTH
- adrenocorticotropic hormone
- CD
- Cushing’s disease
- MRI
- magnetic resonance imaging
- FSH/LH
- Follicle-stimulating hormone / luteinizing hormone
- EV
- extracellular vesicle
- NGS
- next-generation sequencing
- EDTA
- ethylenediaminetetraacetic acid
- qPCR
- quantitative polymerase chain reaction
- Log2FC
- Log2 of fold change